NCT06618703 2026-04-06
BIChE-1
University Hospital, Angers
Phase NA Recruiting
Clinical Trials
49 trialsNCT05212272 2026-03-23
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
Wake Forest University Health Sciences
Phase NA Recruiting
NCT05692635 2026-03-20
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT07467109 2026-03-19
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
M.D. Anderson Cancer Center
Not yet recruiting
NCT07472387 2026-03-16
Andro-iGlio
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting
NCT05890781 2026-02-09
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT07398170 2026-02-09
BIOLIMEN-1
University Hospital, Montpellier
Phase NA Not yet recruiting
NCT03526822 2026-01-28
MM-Predict
Assistance Publique Hopitaux De Marseille
Phase NA Recruiting
NCT06674811 2026-01-26
BRICCS
Mayo Clinic
Recruiting
NCT06147414 2026-01-15
DANNIgene
Assistance Publique - Hôpitaux de Paris
Recruiting
NCT03465618 2026-01-07
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT06575452 2025-12-03
EPIGLIO
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Not yet recruiting
NCT07211841 2025-11-19
GLIOMIT
Centre Hospitalier Universitaire, Amiens
Phase NA Not yet recruiting
NCT07226466 2025-11-10
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
University of California, San Francisco
Not yet recruiting
NCT02530658 2025-10-16
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
St. Jude Children's Research Hospital
Recruiting
NCT05157594 2025-09-22
PROGLIO
Centre Jean Perrin
Completed
NCT06594315 2025-09-18
Assessing Brain Metabolism Using MRS With Deuterated Glucose
University of California, San Francisco
Active not recruiting
NCT06942104 2025-07-18
Imaging of Solid Tumors Using 18F-TRX
University of California, San Francisco
Phase 1 Recruiting
NCT05133154 2025-07-11
GLIOLIPSY
University Hospital, Montpellier
Phase NA Recruiting
NCT04785521 2025-06-11
Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
IRCCS San Raffaele
Active not recruiting
NCT05775458 2025-06-11
Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
IRCCS San Raffaele
Recruiting
NCT05912400 2025-05-08
Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
University of Arkansas
Completed
NCT04025541 2025-04-02
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT06323408 2025-03-25
BZKF-AYA
University Hospital Regensburg
Not yet recruiting
NCT06764537 2025-01-08
BOOSTCAR
Central Hospital, Nancy, France
Phase NA Not yet recruiting
NCT06116903 2024-12-13
ExoGLIE
University Hospital, Limoges
Phase NA Recruiting
NCT06444607 2024-11-21
HEPHESTOS
Radboud University Medical Center
Recruiting
NCT06610851 2024-09-24
GLIBAMIR
University Hospital, Caen
Recruiting
NCT03631953 2024-08-06
ALTREM
Assistance Publique Hopitaux De Marseille
Phase 1 Recruiting
NCT06203496 2024-01-12
GliomiR
University Hospital, Caen
Recruiting
NCT02864563 2023-12-01
PHRCNB07
Institut Curie
Phase NA Completed
NCT03939858 2023-11-08
Bioenergetic Profiling and Cognition in GBM Patients
Wake Forest University Health Sciences
Terminated
NCT03860207 2023-09-13
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
Y-mAbs Therapeutics
Phase 1/2 Terminated
NCT05793021 2023-03-31
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT02022384 2023-02-16
Immunophenotyping From Blood of Patients With Malignant Gliomas
University of Erlangen-Nürnberg Medical School
Completed
NCT03986853 2022-08-04
Explor-AVD
Hopital Foch
Phase NA Terminated
NCT05099068 2022-07-05
PLANET
Centre Leon Berard
Phase NA Unknown
NCT03787056 2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA Recruiting
NCT01674582 2020-09-03
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
Phase NA Completed
NCT04051047 2019-11-27
Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03971812 2019-06-13
GLIOMANOID
Assistance Publique Hopitaux De Marseille
Unknown
NCT02410577 2019-03-19
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03631836 2018-08-17
MARELLE01
Assistance Publique Hopitaux De Marseille
Phase 1 Unknown
NCT02041611 2018-06-27
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00473408 2016-12-06
Gliomstudien
Haukeland University Hospital
Terminated
NCT02680431 2016-02-11
Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
Turku University Hospital
Unknown
NCT01071837 2015-06-16
APG101 in Glioblastoma
Apogenix AG
Phase 2 Completed
NCT00897611 2012-11-30
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT01525459 2012-02-07
Gene Expression, Immunological Status and Metabolome in Glioma Patients
National Institute of Biology, Slovenia
Unknown